Adaptimmune Therapeutics Plc ADR (ADAPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAPY | ACXP | PPBT | ||
| Company | Adaptimmune Therapeutics Plc ADR | Acurx Pharmaceuticals Inc | Purple Biotech Ltd ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0189 | 1.8100 | 3.99 | ||
| High | 0.0189 | 1.9900 | 3.99 | ||
| Low | 0.0061 | 1.7700 | 3.47 | ||
| Latest | 0.0189 | 1.8800 | 3.51 | ||
| Change | unch | +0.0800 | -0.27 | ||
| % Change | unch | +4.44% | -7.14% | ||
| Volume | 38,400 | 155,400 | 20,100 | ||
| 20-Day Average Volume | 407,685 | 133,650 | 7,615 | ||
| Previous Close | 0.0189 | 1.8000 | 3.78 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.0105 | 2.0390 | 4.16 | ||
| 20-Day Raw Stochastic | 80.34% | 22.81% | 2.70% | ||
| 20-Day Relative Strength | 54.54 | 41.21 | 38.80 | ||
| Weighted Alpha | -81.97 | -94.27 | -70.69 | ||
| Today's Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 64% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.50% since 05/12/26 | -8.29% since 05/12/26 | -8.83% since 05/12/26 | ||
| Low | 0.0050 on 05/13/26 | 1.7500 on 05/18/26 | 3.47 on 05/19/26 | ||
| High | 0.0200 on 05/15/26 | 2.0200 on 05/13/26 | 4.05 on 05/15/26 | ||
| 1-Month | |||||
| %Chg | +204.84% since 04/17/26 | -21.01% since 04/17/26 | -27.93% since 04/17/26 | ||
| Low | 0.0001 on 04/30/26 | 1.7500 on 05/18/26 | 3.47 on 05/19/26 | ||
| High | 0.0235 on 05/12/26 | 2.3800 on 04/21/26 | 5.00 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | -24.40% since 02/19/26 | +1.62% since 02/19/26 | -36.41% since 02/19/26 | ||
| Low | 0.0001 on 04/30/26 | 1.3259 on 03/06/26 | 3.47 on 05/19/26 | ||
| High | 0.0300 on 02/25/26 | 7.5392 on 03/19/26 | 5.69 on 02/20/26 | ||
| 6-Month | |||||
| %Chg | -69.02% since 11/19/25 | -53.00% since 11/19/25 | -54.03% since 11/19/25 | ||
| Low | 0.0001 on 04/30/26 | 1.3259 on 03/06/26 | 3.47 on 05/19/26 | ||
| High | 0.0700 on 11/20/25 | 7.5392 on 03/19/26 | 8.90 on 12/01/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,009 | 5,139 | 4,855 | ||
| Shares Outstanding, K | 265,052 | 2,855 | 1,285 | ||
| Annual Sales | 178,030,000 | 0 | 0 | ||
| Annual Net Income | -70,810,000 | -7,970,000 | -26,390,000 | ||
| Last Quarter Sales | 13,680,000 | 0 | 0 | ||
| Last Quarter Net Income | -30,340,000 | -1,680,000 | -90,000 | ||
| 60-Month Beta | 1.89 | -2.09 | 0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/13/25 | -0.62 on 05/12/26 | -19.85 on 03/13/26 | ||
| Earnings Date | 05/19/26 | 08/10/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||